Pharmafile Logo
Pharmafocus logo
Advanced Search
Novartis Gilenya (fingolimod)

Oral MS drug Gilenya launched in the UK

April 19, 2011
Sales and Marketing Novartis, gilenya, multiple sclerosis

Gilenya has become the first oral multiple sclerosis drug to be launched in the UK. Gilenya (fingolimod) is licenced to …

News
Novartis' Afinitor (everolimus)

NICE unimpressed with Novartis’ patient access scheme

April 19, 2011
Sales and Marketing Afinitor, Kidney cancer, NICE, Novartis

Novartis has been dealt a blow by NICE after the cost-effectiveness body finally refused to recommend, on appeal, its kidney …

News

FDA issues guidance on preventing antibiotic cross-contamination

April 19, 2011
Manufacturing and Production FDA, GMP, pharma manufacturing

The FDA has published a new guidance document to help drugmakers prevent cross-contamination of pharmaceuticals with non-penicillin beta-lactam antibiotics. The …

News

Organogenesis to build ‘largest automated living cell facility’

April 19, 2011
Manufacturing and Production Cell biology, Organogenesis, pharma manufacturing

Regenerative medicine specialist Organogenesis has started construction of an automated manufacturing facility for human cells, which it claims will be …

News
Arthritis drug Remicade

J&J and Merck reach compromise on arthritis drug rights

April 19, 2011
Sales and Marketing Johnson & Johnson, Merck & Co, Remicade, Simponi

Johnson & Johnson and Merck & Co have agreed to split the regional rights to arthritis drugs Remicade and Simponi …

News

GlaxoSmithKline OTC sale puts two plants on the block

April 19, 2011
Manufacturing and Production GSK, US, pharma manufacturing

GlaxoSmithKline’s decision to sell off a swathe of over-the-counter medicines means that a manufacturing facility in Memphis, Tennessee, has been …

News
Boehringer Ingelheim

Boehringer’s Pradaxa recommended for expanded European licence

April 18, 2011
Sales and Marketing Boehringer Ingelheim, CHMP, Pradaxa

Pradaxa is on course to expand its European licence with a recommendation from the CHMP for a new indication in …

News
knowledgepoint360_interphase_tim_mustill

Tim Mustill and Jenny Hepburn join InterPhase

April 18, 2011
Sales and Marketing appointment, sales and marketing

KnowledgePoint360 Group has appointed Tim Mustill and Jennifer Hepburn to key positions within its strategic consulting practice InterPhase. Tim has …

Appointment
Pfizer

Phase III boost for Pfizer’s oral arthritis drug

April 18, 2011
Research and Development, Sales and Marketing Pfizer, rheumatoid arthritis, tofacitinib

Pfizer’s rheumatoid arthritis treatment tofacitinib has induced clinical remission of the disease according to one-year data from a phase III …

News

TBA contamination prompts Topamax recall

April 18, 2011
Manufacturing and Production Johnson and Johnson, recalls

Another Johnson & Johnson business unit has decided to recall medicines because of a mouldy smell thought to be caused …

News

VBP: a fait accompli or room for manoeuvre?

April 18, 2011
Sales and Marketing value-based pricing

The pharma industry is seeking a compromise on the UK’s proposed value- based pricing, which promises to revolutionise the country’s …

Feature
Genzyme's headquarters

Genzyme MS drug shines in head-to-head trial with Rebif

April 18, 2011
Research and Development, Sales and Marketing Genzyme, Lemtrada, Sanofi-Aventis, relapsing multiple sclerosis

Genzyme’s multiple sclerosis candidate Lemtrada has impressed in a new phase II head-to-head trial. Five years’ worth of mid-stage data …

News

Fishawack gains industry experts

April 15, 2011
Medical Communications Fishawhack, PR

The Fishawack Group has gained industry experts Linda Harris and Jo Jarvis to expand its stakeholder relations and thought leader …

News

GlaxoSmithKline to drop Alli and other OTC products

April 15, 2011
Research and Development, Sales and Marketing Alli, GSK, OTC, Tyverb

GlaxoSmithKline is to sell off its weight loss drug Alli and other less profitable non-prescription drugs. GSK announced its decision …

News

Elliott maintains pressure on Actelion

April 15, 2011
Sales and Marketing Actelion, pharma mergers and acquisitions

Investment firm Elliott Advisors is maintaining its push for a new leadership team at Actelion.The investment firm is the biggest …

News
Lansley talks to nurse

Nurses’ vote of no confidence a further blow to Lansley

April 14, 2011
Health and Social Care Bill, NHS reforms, Royal College of Nursing

The Royal College of Nurses has voted overwhelmingly against Andrew Lansley’s health reforms, as he receives a vote of no …

News

Pharma manufacturing news in brief

April 14, 2011
Manufacturing and Production Cangene, Chirotech, Grand River Aseptic Manufacturing, Perrigo, West Pharmaceutical Services

India’s Dr Reddy’s Laboratories has opened a new headquarters for its UK subsidiary ChiroTech, along with a new purpose-built laboratory …

News
roche

Roche growth stalls after Avastin setback

April 14, 2011
Research and Development, Sales and Marketing Roche

Revenues at Roche flattened out in the first three months of 2011, as Avastin sales declined in the US and Europe. Group …

News

Watermeadow continues to grow

April 14, 2011
Research and Development Watermeadow, awards, employees, growth

Watermeadow Medical is delighted to welcome seven new staff to its UK offices. The appointments have been made as demand …

Appointment
GP prescribing

GPs asked to squeeze drugs bill

April 14, 2011
Sales and Marketing AZ, GPs, NHS, NICE, prescribing

GPs are being asked not to prescribe NICE-approved drugs in order to cut costs.In the last year more than half …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026